Kolexia
Carola Elisabeth Oncologie médicale
Carola Elisabeth
Oncologie médicale
Centre Hospitalier de Senlis
Senlis, France
94 Activités
65 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du sein Tumeurs du côlon Tumeurs de la prostate Adénocarcinome Fragilité Tumeurs du rectum Métastase tumorale Tumeurs de l'ovaire

Collaborateurs

Voir plus
Soubeyran Pierre-Louis
Soubeyran Pierre-Louis
Institut Bergonié, Bordeaux, France
Paillaud Elena
Paillaud Elena
Hôpital Européen Georges Pompidou, Paris, France
Bengrine-Lefevre Leila
Bengrine-Lefevre Leila
Centre Georges-François Leclerc, Dijon, France
Leger Falandry Claire
Leger Falandry Claire
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Pierre Fabre
13 collaboration(s)
Dernière en 2022
Pfizer
8 collaboration(s)
Dernière en 2023
Lilly
7 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
COLAGE: Phase III Study to Evaluate the Quality of Life in Elderly Patients With Metastatic Colorectal Cancer Receiving First-line Therapy Based on Simplified Geriatric Parameters.
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   02 janvier 2024
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).
BMC cancer   05 janvier 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
213MO Primary endpoint analysis of a randomized phase II of darolutamide or capecitabine in patients with triple-negative androgen receptor-positive advanced breast cancer (UCBG3-06 START trial)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study.
2022 ASCO Annual Meeting I   02 juin 2022
Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
16e Conférence francophone d’Epidémiologie Clinique29è Journées des statisticiens des Centres de Lutte contre le Cancer   01 mai 2022
Abstract P1-18-04: Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
2021 San Antonio Breast Cancer Symposium   15 février 2022